Manager TitleAgeSince
Chief Executive Officer 49 30/05/2025
Director of Finance/CFO 61 30/05/2025
Sales & Marketing 53 31/12/2023
Director TitleAgeSince
Director/Board Member 62 31/12/2019
Chairman 42 31/05/2025
Director/Board Member 75 31/05/2025
Change 5-day change 1-year change 3-year change Capi.($)
-35.15%-30.97% - - 717K
+3.49%+2.32%-28.86%-12.49% 166B
-1.43%+3.32%-5.77%-5.57% 106B
+2.80%+3.33%+1.83%+54.09% 57.69B
+1.33%-0.73%+56.39%+51.86% 53.2B
+0.30%+4.43%-10.83%-40.12% 43.56B
+3.50%+14.35% - - 36.52B
-1.21%+3.79%-14.75%-44.56% 27.49B
+0.55%+5.53%+65.33%-4.37% 25.84B
-9.53%+3.61%-8.42%-3.01% 21.27B
Average -0.91%+4.14%+6.87%-0.52% 59.8B
Weighted average by Cap. +3.31%+3.29%-3.33%+0.12%
Logo ProstaLund AB
ProstaLund AB is a Sweden-based company that provides health care products and services. The Company develops and manufactures urological devices and treatments primarily for benign prostatic hyperplasia (BPH). The Company develops CoreTherm, a patented Thermotherapy treatment method for BPH, which takes approximately 6-15 minutes and offers long-term symptom relief. CoreTherm is used in hospitals and clinics in Sweden and worldwide.
Employees
6
  1. Stock Market
  2. Stocks
  3. PLUN Stock